How Much Does Oral Micronized Progesterone Cost in Michigan in 2026?

Michigan Retail Pricing: Brand vs. Generic vs. Compounded

The average cash price for generic oral micronized progesterone at Michigan retail pharmacies in 2026 sits near $45 per month. Brand-name Prometrium, originally developed by Solvay Pharmaceuticals and now marketed by AbbVie, carries a manufacturer list price around $180 per month. This four-fold difference makes the generic version the default starting point for most patients paying out of pocket.

Compounded progesterone from a Michigan-licensed 503A pharmacy drops the price further to roughly $25 per month. The cost advantage is real, but FDA-approved products (generic or brand Prometrium) carry standardized bioavailability testing that compounded capsules do not undergo. The PEPI trial (Postmenopausal Estrogen/Progestin Interventions, N=875) established that oral micronized progesterone at 200 mg per day for 12 days per cycle effectively opposed estrogen-stimulated endometrial hyperplasia while producing a more favorable lipid profile than medroxyprogesterone acetate 1. That evidence base applies directly to the FDA-approved formulations with documented dissolution profiles.

Michigan has no state-level price cap on progesterone prescriptions, so pharmacy-to-pharmacy variation can be significant. Prices at independent pharmacies in Detroit, Grand Rapids, and Ann Arbor may differ by $10 to $20 for the same generic product. Checking multiple pharmacies or using a discount pricing tool before filling the prescription is a practical step.

Michigan Medicaid Coverage and Prior Authorization

Michigan Medicaid covers oral micronized progesterone for endometrial protection during estrogen-based hormone replacement therapy, but a prior authorization (PA) is required. The PA process typically requires the prescribing clinician to document that the patient is receiving concurrent estrogen therapy and that progesterone is being prescribed for an FDA-approved or medically accepted indication.

Processing times for PA requests through Michigan's Medicaid pharmacy benefit manager range from 24 to 72 hours for standard requests. Urgent requests tied to active HRT regimens sometimes receive same-day approval. The FDA-approved labeling for Prometrium specifies two indications: prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens, and treatment of secondary amenorrhea. Michigan Medicaid PA criteria track these labeled indications closely.

Healthy Michigan Plan enrollees (the state's Medicaid expansion population) follow the same PA pathway. Co-pays under Healthy Michigan Plan are capped at $3 for preferred generics, making the out-of-pocket cost for approved progesterone prescriptions minimal once authorization is granted. For women already enrolled in Medicaid who are starting HRT, asking the prescriber to submit the PA concurrently with the estrogen prescription avoids a gap in therapy.

The Endocrine Society's 2022 clinical practice guideline on menopausal hormone therapy recommends micronized progesterone as the preferred progestogen for endometrial protection based on its neutral-to-favorable cardiovascular and breast tissue risk profile compared to synthetic progestins 2. Michigan formulary committees have cited this guideline as supporting evidence for maintaining Medicaid access to micronized progesterone despite the PA step.

Private Insurance Coverage Across Michigan

Most commercial insurance plans sold on the Michigan Health Insurance Marketplace and employer-sponsored plans from Blue Cross Blue Shield of Michigan, Priority Health, HAP (Health Alliance Plan), and McLaren Health Plan include generic oral micronized progesterone on their formularies. Tier placement varies. Generic progesterone typically lands on Tier 1 (preferred generic) with copays between $5 and $15 per month. Brand Prometrium, when covered, usually falls on Tier 2 or Tier 3, with copays of $30 to $75.

Step therapy requirements are uncommon for progesterone because the generic version is already the lowest-cost option. Some plans do require the prescriber to specify "oral micronized progesterone" rather than "Prometrium" to trigger generic dispensing automatically. A 2023 analysis published in the Journal of Women's Health found that formulary restrictions on HRT medications increased therapy discontinuation rates by 18% over 12 months compared to unrestricted access 3. Patients encountering denials should request a formulary exception with clinical documentation from their provider.

Dr. JoAnn Manson, chief of preventive medicine at Brigham and Women's Hospital and principal investigator of the Women's Health Initiative hormone therapy trials, has stated: "Micronized progesterone offers a safety advantage over synthetic progestins for most women on HRT, and access barriers to this medication are not clinically justified when estrogen therapy has already been approved" 4.

For women with high-deductible health plans (HDHPs), progesterone costs apply to the deductible until it is met. Using a pharmacy discount card alongside insurance is generally not permitted at the point of sale, but patients can compare the cash-pay discount price against their plan's negotiated rate and choose the lower option at the pharmacy counter.

Compounded Progesterone in Michigan: Legal Status and Considerations

Compounded progesterone is legal in Michigan through 503A-licensed compounding pharmacies. These pharmacies operate under state Board of Pharmacy oversight and prepare medications based on individual prescriptions. Michigan does not restrict progesterone compounding specifically, and multiple 503A pharmacies across the state (concentrated in metro Detroit, Grand Rapids, Kalamazoo, and Traverse City) offer compounded oral micronized progesterone capsules.

The price advantage is clear: $25 per month compared to $45 for FDA-approved generics. The tradeoff involves quality assurance. FDA-approved progesterone products undergo dissolution testing, content uniformity analysis, and bioequivalence studies. Compounded capsules do not face these requirements. A 2019 FDA survey of compounded hormone therapy products found that 34% of tested samples failed one or more quality standards, including potency 5.

Dr. Nanette Santoro, professor of obstetrics and gynecology at the University of Colorado School of Medicine and past president of the North American Menopause Society, has noted: "When an FDA-approved equivalent exists at a reasonable cost, compounded hormones should not be the default recommendation. The regulatory oversight difference is meaningful for patient safety."

Michigan patients choosing compounded progesterone should verify that their pharmacy holds current 503A registration with the Michigan Board of Pharmacy and ask whether the pharmacy participates in third-party potency verification programs. Some compounding pharmacies voluntarily submit batches to independent labs and make certificates of analysis available upon request. This is a reasonable quality checkpoint for patients who opt for the compounded route.

Telehealth Prescribing of Progesterone in Michigan

Michigan permits telehealth prescribing of oral micronized progesterone. Following pandemic-era regulatory expansions, Michigan's Public Health Code (MCL 333.16284) allows prescribers to establish a valid patient-prescriber relationship via synchronous audio-video telehealth visits. Progesterone is not a controlled substance, so no in-person visit requirement applies.

Several telehealth platforms operating in Michigan now prescribe HRT medications including micronized progesterone. Typical consultation fees range from $50 to $150 for an initial visit, with follow-up visits at $30 to $75. Some platforms bundle the cost of the medication with the consultation fee. Patients in rural Michigan counties (the Upper Peninsula, northern Lower Michigan) benefit most from telehealth access, as endocrinology and menopause-specialty providers are concentrated in the southeastern and western Michigan metro areas.

Telehealth prescriptions are filled at the patient's pharmacy of choice, including mail-order pharmacies. Mail-order options can reduce per-month costs by $5 to $10 through 90-day supply pricing. The Endocrine Society's position statement on telehealth supports remote management of hormone therapy for stable patients, recommending in-person evaluation only when clinical findings require physical examination 6.

How to Get the Lowest Price in Michigan

For patients without insurance or with high out-of-pocket costs, a step-by-step approach minimizes what you pay for oral micronized progesterone in Michigan.

Step 1: Start with generic. Always request generic oral micronized progesterone rather than brand Prometrium. The active ingredient and peanut-oil suspension are identical in the FDA-approved generics.

Step 2: Compare pharmacy prices. Cash prices vary by $10 to $20 across Michigan pharmacies. Costco and Walmart pharmacies in Michigan typically price generic progesterone below the $45 state average (Costco does not require a membership for pharmacy purchases in Michigan).

Step 3: Use a discount card. GoodRx, RxSaver, and Amazon Pharmacy discount programs frequently bring the price of 30 capsules of 100 mg generic progesterone below $30 at participating Michigan pharmacies. These are free to use.

Step 4: Consider 90-day fills. A 90-day supply reduces per-month cost by roughly 15% to 20% at most Michigan pharmacies and mail-order services.

Step 5: Evaluate compounding only after FDA-approved options. If $25 per month at a 503A compounding pharmacy is the best available price and cost is the primary barrier, confirm the pharmacy's licensure and quality-testing practices before filling. The Women's Health Initiative long-term follow-up data (median 18 years) confirmed that estrogen plus micronized progesterone carries a more favorable safety signal than estrogen plus medroxyprogesterone acetate 7, but this evidence was generated using standardized, FDA-approved formulations.

Step 6: Check manufacturer savings programs. AbbVie offers a Prometrium copay card that can reduce brand copays to as low as $25 per month for commercially insured patients. This card does not apply to government insurance (Medicaid, Medicare Part D, Tricare). Eligibility and terms change periodically, so confirm current details at the pharmacy counter.

Michigan-Specific Discount and Assistance Programs

Michigan has no state-operated pharmaceutical assistance program for hormone therapy medications specifically. The MIRx prescription discount card program, administered by the Michigan Department of Health and Human Services, closed to new enrollees in 2019. Current discount options for Michigan residents include:

Manufacturer copay cards. The Prometrium savings card from AbbVie typically reduces brand copays for commercially insured patients. It does not apply to cash-pay purchases of generics.

Pharmacy-based discount programs. Meijer, a Michigan-headquartered grocery and pharmacy chain, includes select women's health medications in its free or low-cost generic drug program. Verify progesterone's inclusion at your local Meijer pharmacy, as the list updates quarterly.

Nonprofit patient assistance. The NeedyMeds database (needymeds.org) and the Patient Advocate Foundation both maintain directories of assistance programs applicable to HRT medications. Income-qualified patients (typically at or below 300% of the federal poverty level) may access brand medications at no cost through manufacturer PAPs (Patient Assistance Programs).

Federally Qualified Health Centers (FQHCs). Michigan has over 40 FQHC organizations operating 300+ sites statewide. FQHCs dispense medications through the 340B Drug Pricing Program, which can reduce progesterone costs below retail pricing. Patients receiving care at an FQHC are automatically eligible for 340B pricing regardless of insurance status 8.

Clinical Context: Why Micronized Progesterone Over Synthetic Progestins

The cost discussion matters only if the medication is the right clinical choice. The PEPI trial (N=875) demonstrated that oral micronized progesterone 200 mg cyclically opposed endometrial hyperplasia as effectively as medroxyprogesterone acetate 10 mg cyclically, while micronized progesterone preserved HDL cholesterol levels that MPA reduced by 2.4 mg/dL 1.

The E3N French cohort study (N=80,377 postmenopausal women, mean follow-up 8.1 years) found that estrogen combined with micronized progesterone did not significantly increase breast cancer risk (RR 1.00 to 95% CI 0.83 to 1.22), while estrogen combined with synthetic progestins increased risk significantly (RR 1.69 to 95% CI 1.50 to 1.91) 9. This safety differential is the primary reason clinical guidelines now favor micronized progesterone for endometrial protection.

The 2022 North American Menopause Society position statement recommends micronized progesterone as first-line for endometrial protection during menopausal HRT, and specifies that "the choice of progestogen type, route, and dose should factor in the differential breast and cardiovascular risk profiles supported by current evidence" 10.

For Michigan patients starting HRT, the generic form of oral micronized progesterone at $45 per month represents the intersection of evidence-based safety, FDA manufacturing standards, and accessible pricing.